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L-2-hydroxyglutaric aciduria (L2HGA) is a neurometabolic disorder characterized by macrocephaly, seizures,
progressive mental retardation, pyramidal signs, ataxia and tremor. Dystonia is an under-recognized feature of this
entity in the literature. We report two siblings with L2HGA, one of whom presented with writer’s cramp followed by
dystonia of the other hand. An elevated plasma lysine, highly elevated urine 2-hydroxyglutaric acid, and MRI with
characteristic findings (leukoencephalopathy of bilateral subcortical white matter sparing central white matter)
suggested the diagnosis, which was confirmed by genetic testing.
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L-2-hydroxyglutatric aciduria (L2HGA) is a neurometabolic
disorder in the family of cerebral organic acid disorders, ex-
amples of which include glutaric aciduria type I, saccharopi-
nuria, 2-amino-/2-oxo-adipic aciduria, D-2-hydroxyglutaric
aciduria and Canavan’s disease (N-acetylaspartic aciduria)
[1]. L2HGA is an autosomal recessive disorder with the
defective gene encoding a Flavin Adenine Dinucleotide
(FAD)-dependent L-2-hydroxyglutarate dehydrogenase.
The typical clinical presentation includes macrocephaly
and progressive neurologic signs such as febrile and afebrile
seizures, cerebellar deficits (gait and limb ataxia), speech
problems, learning disabilities and developmental delay,
and pyramidal signs [2]. Movement disorders described in
the literature in these patients include tremor, dystonia
and ataxia [2-4]. We present two siblings with L2HGA,
one of whom presented with focal hand dystonia, to call
attention to this unusual condition.Case presentation
Case 1
The proband is a 15-year-old Egyptian girl. She developed
difficulty writing with her right hand at age 8. The prob-
lem started selectively with writing but soon spread to in-
volve other tasks. She switched to writing with her left
hand, and developed writing problem two years later.* Correspondence: Pichet.Termsarasab@mountsinai.org
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article, unless otherwise stated.Subsequently she developed problems with other tasks in-
cluding holding utensils and using a computer for school.
She had slow developmental milestones and some cogni-
tive impairment but no history of seizures. Her ethnic
background is Egyptian/Turkish and Egyptian/Syrian on
maternal and paternal sides respectively, with no known
consanguinity.
Physical examination revealed no macrocephaly. Eye
movements were normal, and her speech was slightly
scanning but not dysarthric. As soon as she picked up
a pen to write, there was moderate to severe action
dystonia in both arms, more prominent on the left.
There was no null point or geste antagoniste (Figure 1
and Additional file 1). There was no rest or action tremor.
There was mild dysmetria on finger-to-nose testing. Gait
was normal.
Biochemical testing revealed elevated plasma lysine
and highly elevated urine 2-hydroxyglutaric acid. Molecu-
lar genetic testing showed a heterozygous mutation in the
L2HGDH gene – c.584A>G and c.1115delT. MRI of the
brain revealed marked diffuse subcortical white matter
abnormalities with hypointense and hyperintense sig-
nals on T1 and T2 images, and relative sparing of cen-
tral white matter. There were also hyperintense signals
in both dentate nuclei on T2 images (Figure 1A-E). MR
spectroscopy revealed a high lactate peak and reduced
N-acetylaspartate to creatine ratio (Figure 1F). She was
treated with trihexyphenidyl up to 6 mg/day, but could not
tolerate it due to the side effect of worsening cognition.ed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Panels A to E reveal the MRI of patient 1. A and B, axial sections of T2-weighted images (T2WI); C, mid-sagittal plane of T2WI; D and
E, coronal sections of T1WI and T2WI, respectively; F, MR spectroscopy of voxel at subcortical white matter. MRI shows white matter changes in
subcortical region diffusely, seen as hypointense and hyperintense signal on T1WI and T2WI, respectively. There is sparing of central white matter.
There is also T2-hyperintense signal at bilateral dentate nuclei (panel A).
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takes riboflavin.
Case 2
The sister of patient one is sixteen. She had delayed devel-
opmental milestones starting in early childhood, but was
not tested until her younger sister manifested the symp-
toms. On examination, she had mild kinetic tremor of both
hands, and finger-to-nose test showed mild past-pointing.
Her speech was mildly scanning with no dysarthria. She
could not perform tandem walking. There was no evidence
of dystonia.
MRI of the brain showed findings similar to the proband,
and genetic testing also revealed the same mutation as
the proband. She is also on riboflavin but on no medication
for tremor.
Discussion
The diagnosis of L2HGA is usually considered when
plasma amino acid and urine organic screening tests show
elevated lysine and 2-hydroxyglutaric acid, respectively.
We suspect that few movement disorder neurologists
would consider L2HGA in a young patient with writer’s
cramp. Indeed, lists of causes of secondary dystonia in
major movement disorder textbooks do not even include
this condition.The phenomenology of movement disorders in L2HGA
reported in the literature includes dystonia, tremor, ataxia
and rarely myoclonus. Dystonia has been described affect-
ing the hands and upper limbs [4]. Tremor described in
the literature is mostly intention tremor, similar to the
intention tremor of case 2. Ataxia can affect either the
trunk or limbs [2], and mild myoclonus in the upper ex-
tremity has been reported in one patient [2].
Although the most common initial presentation re-
ported by Barth and colleagues were walking delay and
gait abnormality (6 out of 8 patients), movement disor-
ders may be under-recognized [2]. Balaji et al. recently
described 2 siblings with L2HGA, one of which with
dystonia of the head, trunk and upper extremities, the
other with dystonia of distal upper and lower extrem-
ities [5]. In our patient (proband), the initial presenta-
tion that prompted her parents to bring her to medical
attention was writer’s cramp. Focal task-specific dys-
tonia of the arm is unusual in childhood outside of the
setting of DYT-1 dystonia. It has also been reported in
myoclonus-dystonia syndrome (DYT-11) [6,7] and X-
linked dystonia-parkinsonism (DYT-3). Writer’s cramp
has been reported as a presentation in a limited number
of secondary dystonias in children such as basal ganglia
arteriovenous malformations [8], basal ganglia infarction
[9], Wilson’s disease, Huntington’s disease, pantothenate
Figure 2 Handwriting of patient 1, when on trihexyphenidyl 2 mg/day. The upper, middle and lower rows demonstrate handwriting when
she was allowed to write with only the right or the left hand, respectively. Her handwriting was worse with the right hand, correlated with the
degree of dystonia in each hand.
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aciduria, GM1 gangliosidosis, and Leigh’s disease. L2HGA
should be added to the list of secondary dystonias of
childhood.
In the Krebs cycle, 2-ketoglutaric acid is usually
catalyzed by the enzyme L-malate dehydrogenase to
L-2-hydroxyglutaric acid. It has been proposed that
L-2-hydroxyglutaric acid is an unwanted substrate which
then requires a “repair” enzyme, L-2-hydroxyglutaric acid
dehydrogenase, to shift it back to 2-ketoglutaric acid
in the Krebs cycle [10]. This “repair” enzyme is deficient
in L2HGA. MRI findings in this disorder are unique,
and once seen, are pathognomonic. The neuroradiologic
differential diagnoses of leukoencephalopathy with grey
matter signal abnormalities (with neuroanatomical struc-
tures involved in parenthesis) include Canavan’s disease
(globus pallidi, dentate nuclei), L2HGA (basal ganglia,
dentate nuclei), Alexander’s disease (deep grey matter,
dentate hilum), GM1/GM2 gangliosidoses (basal ganglia),
Krabbe’s disease (thalami, dentate nuclei), and maple
syrup urine disease (thalami, globus pallidi) [11].
Although treatment options are limited in L2HGA, it is
important to recognize this disorder as it is associated with
malignant brain tumors such as glioblastoma and primitive
neuroectodermal tumor [12], requiring close surveillance.
Riboflavin treatment [13] and protein restriction may have
a role, but data is limited. FAD and levocarnitine chloride
were also reported as treatment options [14].
An animal model of L2HGA has been described in
Staffordshire Bull Terriers, with seizures, ataxia, tremor,
and dementia [15,16].Conclusion
It is important to have a high index of suspicion of sec-
ondary dystonia when evaluating pediatric patients who
initially present with upper extremity dystonia or writer’s
cramp. We illustrate the example of this phenotype as an
initial presentation of L2HGA.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for review
by the Editor-in-Chief of this journal.Additional file
Additional file 1: Video 1. The speech of patient 1 was normal. There
was dystonia of bilateral hands, left greater than right, with spooning of
the fingers. She did not have tremor or ataxia. During writing, there was
moderate extension of the right wrist and abduction of the right elbow.
There was no mirror dystonia when she wrote with the left hand. There
was excessive bilateral arm swing during walking. The latter segment
of the video shows examination 3 months after she was treated with
trihexyphenidyl 6 mg/day. She preferred to write with both hands.
Writer’s cramp was slightly improved from the previous examination
when she was allowed to write with only the right hand. Right focal
hand dystonia was also mildly better when she held the pen between
her right index and middle fingers. There was mild flexion of the left
wrist when she wrote with her left hand. The dose of trihexyphenidyl
was subsequently reduced due to cognitive side effects.Competing interests
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